Walking Study for Stroke Rehabilitation

NCT00428480 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2011-11-11

No results posted yet for this study

Summary

The primary purpose of this study is to determine the effects of reinforcement of walking speed on recovery of walking speed over the course of inpatient rehabilitation for people after stroke. The study will also examine the relationship between short distance walking speed and walking distance over a fixed time.

Conditions

Interventions

BEHAVIORAL

Daily reinforcement of walking speed (DRS)

Inpatients are encouraged to walk faster and given feedback on their walking speed during a daily 10-meter walk as part of their usual physical therapy.

BEHAVIORAL

No reinforcement of walking speed (NRS)

Inpatients complete a 10-meter walk as part of their daily physical therapy but are not given any encouragement to walk faster or feedback on their walking speed.

Sponsors & Collaborators

  • WORLD FEDERATION FOR NEUROREHABILITATION

    collaborator UNKNOWN
  • Mayo Clinic

    collaborator OTHER
  • The Foundation Institute San Raffaele G. Giglio of Cefalù

    collaborator OTHER
  • University of Vigo

    collaborator OTHER
  • Morinomiya Hospital, Osaka, Japan

    collaborator UNKNOWN
  • Chonnam National University Hospital

    collaborator OTHER
  • Asklepios Kliniken Hamburg GmbH

    collaborator OTHER
  • Burke Rehabilitation Hospital

    collaborator OTHER
  • Hacettepe University

    collaborator OTHER
  • Department of Rehabilitation, University Hospital, Czech Republic

    collaborator OTHER
  • Federal Medical Center, Abeokuta, Nigeria

    collaborator UNKNOWN
  • Ankara University

    collaborator OTHER
  • Institute for Clinical Research

    collaborator OTHER
  • University of Chicago

    collaborator OTHER
  • Helen Hayes Hospital

    collaborator OTHER
  • Gazi University

    collaborator OTHER
  • All India Institute of Medical Sciences

    collaborator OTHER
  • Shirley Ryan AbilityLab

    collaborator OTHER
  • St. Luke's Hospital, Pennsylvania

    collaborator OTHER
  • Hochzirl Hospital

    collaborator OTHER
  • Father Muller Medical College

    collaborator OTHER
  • Kernan Hospital, Baltimore

    collaborator UNKNOWN
  • IRCCS San Camillo, Venezia, Italy

    collaborator OTHER
  • Kessler Foundation

    collaborator OTHER
  • Vanderbilt Stallworth Rehabilitation Hospital, TN

    collaborator UNKNOWN
  • Rehabilitation Hospital of Rhode Island, RI

    collaborator UNKNOWN
  • St. Mauritius Therapieklinik, Dusseldort, Germany

    collaborator UNKNOWN
  • University of California, Los Angeles

    lead OTHER

Principal Investigators

  • Bruce H Dobkin, MD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States
  • Austria
  • Germany
  • India
  • Italy
  • Japan
  • Nigeria
  • South Korea
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00428480 on ClinicalTrials.gov